Videos

Researchers have discovered that leptin, a hormone linked to energy metabolism, plays a crucial role in driving neuropathic pain in women but not in men, opening the door to targeted pain treatments.

Panelists discuss how intrauterine device (IUD) usage rates are increasing but remain low despite the availability of hormonal and new copper options. Obstacles include physician education gaps, patient anxieties about procedures, high up-front costs (especially for the uninsured), and misconceptions about fertility risks that modern IUDs do not pose.

Wanda Filer, MD, MBA FAAFP, from Pelvital, discusses how the Flyte device uses groundbreaking mechanotherapy to provide an effective, non-surgical solution for stress urinary incontinence.

Many women struggle with stress urinary incontinence but delay treatment because of embarrassment and lack of awareness, highlighting a need for screening and innovative treatments.

John PFA Heesakkers, MD, PhD, MBA, with Maastricht Universitair Medisch Centrum, highlights a study revealing that the Revi System significantly reduces urinary incontinence episodes, offering a side-effect-free alternative to traditional treatments with high patient satisfaction.

Panelists discuss how nearly 46% of pregnancies in the US are unplanned. Although this rate has declined, the US still has one of the highest rates of unplanned pregnancies in the world, particularly affecting minority and disadvantaged communities.

Shirley Wang, a PhD student in the School of Pharmacy at the University of Waterloo, discusses the findings on Levetiracetam’s safety during breastfeeding and how mothers can make informed decisions about medication use and infant health.

Discover how regular, moderate physical activity can boost mental well-being in women with chronic pelvic pain disorders such as endometriosis, adenomyosis, and fibroids.

Jannah Thompson, MD, FPMRS, discusses how the Neuspera sacral neuromodulation system encourages patient involvement, improving long-term treatment success and offering broader applicability for those with urge urinary incontinence.

A new study on the Neuspera sacral neuromodulation system reveals that 84% of patients experienced significant symptom improvement, offering a minimally invasive, battery-free solution for urgency urinary incontinence.

Black women in the United Kingdom face lower breast cancer screening rates and higher mortality risks, highlighting barriers they encounter and how health care professionals can bridge the gap.

A review of studies reveals that Black women face unique cultural, emotional, and health care-related barriers to breast cancer screening, highlighting the need for targeted interventions and inclusive research.

Many women in their 30s experience perimenopausal symptoms but dismiss them as normal, preventing them from seeking interventions that could improve their quality of life.

Learn how women aged 30 to 35 years may be experiencing symptoms of perimenopause at a younger age than expected, as discussed by Jennifer Lanier Payne, MD, of UVA Health.

Somi Javaid, MD, FACOG, urges clinicians to prioritize sexual health care through specialized training or referrals, highlighting the importance of patient empowerment and emerging treatments such as testosterone therapy and pelvic floor health tools.

Discover how a comprehensive biopsychosocial approach addressing biological, psychological, and social factors can improve sexual health, boost confidence, and enhance overall well-being.

Despite sexual health being a fundamental right, women face significant disparities in treatment, awareness, and insurance coverage—highlighting the need for systemic change.

As in vitro fertilization procedures evolve with new technologies and extended embryo care, embryologists face increasing workloads, higher stress levels, and the challenge of maintaining precision, leading to concerns about burnout and efficiency in the lab.

New research from NYU Grossman School of Medicine reveals that maternal health conditions during pregnancy are correlated with autism risk but are not a direct cause, highlighting the role of genetic and familial factors.

Discover how Mirvie’s RNA platform uses a simple blood test to detect fetal growth restriction early in pregnancy, allowing for proactive interventions and improved outcomes for mothers and babies.

Learn how carrier screening and noninvasive prenatal testing help expectant parents identify genetic risks early, explore reproductive options, and prepare for the best possible pregnancy outcomes.

Discover the latest advancements in prenatal genetic screening, the challenges preventing access, and how increased awareness can help expecting parents make informed decisions.

Discover how maternal fetal medicine specialists are tackling maternal mortality disparities through trust-building, diverse care teams, and comprehensive support programs.

The FDA-cleared and CLIA-waived cobas liat sexually transmitted infection multiplex assay panels offer rapid, point-of-care testing for chlamydia, gonorrhea, and mycoplasma genitalium.

Timely diagnosis of gestational diabetes is crucial for optimal maternal and fetal health, but a recent study highlights demographic disparities in screening delays and the need for further research on potential health impacts.

A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.

Learn how complex contraceptive counseling helps individuals with medical conditions such as heart disease, lupus, and breast cancer find safe, effective birth control options tailored to their unique needs.

Daniel L. Kuhr, MD, maternal fetal medicine fellow at Mount Sinai, discusses the role of neighborhood-level indices in predicting spontaneous preterm birth risk and why individual patient characteristics remain the key factor.

A new randomized control trial reveals that barbed sutures significantly reduce blood loss during hysterotomy, offering valuable insights for improving clinical outcomes in obstetric surgery.

A new study explores the potential link between antiretroviral therapy, specifically integrase inhibitors, and fetal biometric measurements, shedding light on possible pregnancy complications.